Hamlet BioPharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Catharina Svanborg | 34,28 | 74,84 | 2024-12-23 |
| Nordnet Pensionsförsäkring | 6,15 | 2,03 | 2024-12-23 |
| Avanza Pension | 5,58 | 1,91 | 2024-12-23 |
| Rolf Karlsson | 3,68 | 1,22 | 2024-12-23 |
| Hans Nygren | 1,84 | 0,61 | 2024-12-23 |
| Gramsh Gashi | 1,70 | 0,56 | 2024-12-23 |
| Nordea Liv & Pension | 1,49 | 0,49 | 2024-12-23 |
| Creative Invest One AB | 0,83 | 0,27 | 2024-12-23 |
| Försäkringsaktiebolaget Skandia | 0,73 | 0,25 | 2024-12-23 |
| Creative Networks X AB | 0,50 | 0,17 | 2024-12-23 |
2025-05-22 Delårsrapport 2025-Q3
2025-08-28 Bokslutskommuniké 2025
2025-11-14 Delårsrapport 2026-Q1
2025-11-20 Årsstämma 2025
